FDA Clearance Tracker · P040029-S006
Euclid Systems Orthokeratology (oprifoconA)/ Contact Lenses for Overnight Wear/Euclid Systems Orthokeratology (tisilfoco
Last checked: Nov 20, 2026Latest source record: Aug 7, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Aug 7, 2019
Approved
Time to decision
677 days
Received Sep 29, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040029-S006
- Device name
- Euclid Systems Orthokeratology (oprifoconA)/ Contact Lenses for Overnight Wear/Euclid Systems Orthokeratology (tisilfoco
- Applicant
- Euclid Vision Corporation
- Applicant location
- Sterling, VA
- Received
- Sep 29, 2017
- Decided
- Aug 7, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040029
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for new manufacturing site at Euclid Systems Corporation, 45472 Holiday Drive, Suite 7, Sterling, VA.
Source documents
Other decisions for Euclid Vision Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.